INTRODUCTION
Urokinase plasminogen activator (uPA) cleaves plasminogen to generate another serine protease, plasmin, whose activity has been linked to events such as cell migration and tissue reorganization in both normal and pathological conditions (1) (2) (3) . The gene for uPA is located on chromosome 10 (4,5), contains 11 exons (6) , and codes for a 52kd protein via a 2.5kb mRNA (7) . The production of uPA is regulated by peptide and steroid hormones, growth factors, cyclic nucleotides and tumour promoters (3, 7, 8) . There is evidence for transcriptional control of uPA gene expression by some of these agents (8) (9) (10) (11) . The tumour promoter, phorbol myristate acetate (PMA), has been shown to increase uPA mRNA levels rapidly, and the induction is independent of protein synthesis and strongly amplified in the presence of inhibitors of protein synthesis (11) , such as cycloheximide (CHX). Comparable superinduction of transcription is seen in genes that are regulated by growth factors via a serum response element (SRE),such as the fos gene (12) (13) (14) .
We have studied the mechanism of the superinduction of uPA mRNA levels by several agents in the presence of CHX. This superinduction is caused by strong transcriptional activation. We describe the significance of a DNA element, present in the uPA gene promoter at position -1865 with respect to the start site of transcription (6) , for the regulation of the uPA gene by interleukin-1 (IL-1), tumor necrosis factor a (TNFa) and PMA, as well as for the superinduction by these agents in the presence of CHX. This regulatory element contains sequences similar to known binding sites for the transcription factor NFkB.
MATERIALS AND METHODS

Cell culture and transfections
The human cervical carcinoma HeLa cell line was grown in Dulbecco's modified Eagles medium, supplemented with 10% foetal bovine serum. Twenty hours prior to transfection, HeLa cells were plated at a density of 1.5X 10 6 per 10cm plate. Ten microgram of CAT-plasmid together with 5 microgram of pRSVluciferase (gift from Dr. J.Zajac) were transfected into the cells using the calcium phosphate-coprecipitation method. Twenty four hours after transfection, PMA(100 nM), IL-1 (100 U/ml)(gift from Dr. P.Lomedico, Hoffmann-La Roche, Nutley, N.J.), or human recombinant TNFa (5 nM)(gift from Boehringer Ingelheim,Sydney)+/-CHX (10 /tg/ml) were added to the cells for three hours unless stated otherwise. This was followed by a medium change and additional incubation for another three hours to allow the translation of the accumulated mRNA, as described (13, 14) . The assay for CAT-enzyme activity was performed as published (15) . Luciferase activity was analysed with the help of a luminometer as described (16) and the values were used to monitor DNA uptake during transfection. All constructs were transfected into HeLa cells and assayed three to five times independently. gene and the splice site and polyadenylation signal from the SV40 virus, but no functional promoter. The resultant plasmid p2.3CAT was used for the construction of several deletion mutants, making use of restriction enzymes, which cleave the promoter region only rarely.
The plasmid pd24, as well as the plasmid pTKCAT, which contains the CAT gene under the control of the minimal promoter of the herpes simplex virus thymidine kinase gene, were used for the construction of plasmids containing synthetic oligonucleotides. The oligonucleotides were synthesised on a DNA synthesiser from Applied Biosystems and contained the sequences of interest framed by appropriate overlapping ends, which allowed cloning into the BamHI site of the respective plasmids (Table I ). All resulting constructs were verified by DNA sequence analysis. 
RNA analysis
Total cellular RNA was extracted with guanidinium thiocyanate (17) and subjected to electrophoresis in formaldehyde containing agarose gels. After blotting onto Hybond membranes (Amersham), the RNA was hybridized to human uPA cDNA (gift from Dr. R.Miskin), followed by autoradiography.
RESULTS
Induction of urokinase (uPA) mRNA in HcLa cells by phorbol esters is independent of protein synthesis and is superinduced by inhibiton of protein synthesis
We studied the induction of uPA mRNA levels in HeLa cells as they express the uPA gene constitutively at very low levels (Figure 1 A,lane a). PMA (lOOnM) increased the steady state levels of uPA mRNA several fold within four hours (Figure 1 A,lane b). Time course experiments revealed that the levels of uPA mRNA increase over seven hours after addition of PMA ( Figure IB, lanes b,c,d .). Addition of CHX (10/tg/ml) alone to the medium had no effect on uPA mRNA levels ( Figure. . The maximal levels of uPA gene induction in the presence of PMA and CHX were reached within three hours and remained at the same level for at least another four hours ( Figure IB) . Superinduction of transcription in the presence of agents which inhibit protein synthesis is likely to be the result of the decay of a labile repressor. As culture of the cells with CHX alone did not increase uPA mRNA levels, experiments were carried out to analyse the kinetics of gene induction after pretreatment of the cells with either CHX or PMA for two hours before culturing with PMA and CHX together. HeLa cells cultured for one to four hours in the presence of PMA and CHX accumulated the same uPA mRNA levels, irrespective of prior pretreatment with either PMA or CHX alone for two hours ( Figure 1C ). This suggests that the repressor is not accessible to rapid degradation during treatment of the cells with CHX alone. Treatment of the cells with PMA, however, causes the repressor to become labile and accessible to degradation. Similarly, IL-1 and TNFa superinduced uPA mRNA levels in the presence of CHX (data not shown). The time course of induction of the mRNA was about the same for all three reagents. Superinduction of the uPA gene by PMA in the presence of CHX is mainly due to increased gene transcription In order to assess the role of transcription in the observed superinduction by PMA and CHX, we constructed plasmids in which the chloramphenicol acetyl transferase (CAT)-gene is placed under the control of the uPA gene promoter. The construct p2.3CAT contains promoter sequences from -2350 to +30bp (6) with respect to the start site of transcription ( Figure 2 ). Twenty four hours after transfection of 10 /tg of the CATconstructs p2.3CAT or pdl 1 into HeLa cells, drugs were added to the medium for the times indicated in Table II . This was followed by a change to drug-free medium and several hours of incubation, during which the accumulated mRNA was translated. The CAT-activity in extracts derived from the cells was increased three to six fold by PMA or IL-1 (data not shown) alone within three to four hours, but not by CHX. However, in the presence of CHX, PMA caused an increased CAT-activity of up to 100 fold (Table II) . The levels of induction due to PMA or IL-1 alone were about the same in all experiments. However the levels of superinduction obtained in the presence of CHX varied from experiment to experiment. Control plasmids, such as pRSVCAT or pTKCAT, showed a 1-3 fold increase in CAT-activity in the presence of PMA and CHX (Table IS) . This increase could be partly due to an effect on mRNA stabilisation. The time course of induction of the fusion uPA-CAT gene followed similar kinetics as the induction of the endogenous uPA gene in HeLa cells i.e., there was a significant increase within two hours and maximal levels were reached within three hours (Table II) . This Cell treatment plasmid p2.3CAT control, DME 9h PMA 9h PMA+CHX 2h PMA+CHX 4h PMA+CHX 6h CHX 6h plasmid pdll control, DME 9h PMA 9h PMA+CHX 3h PMA+CHX 6h CHX 3h CHX 6h +7h DME +5h DME +3h DME +3h DME +6h DME +3h DME +6h DME +3h DME mutants above 1 to 3 fold. Clone pd24, which only retains the promoter sequences from -408 to +30, could not be induced. The observed CAT gene activity of this mutant was very low, which is in accordance with reports of a transcriptional enhancer in the region between -2350 and -1816 (18) . All mutants, which could be regulated by PMA and CHX could also be regulated by IL-1 or TNFa together with CHX (data not shown).
These results indicate that the DNA sequences required for the induction of the uPA gene by PMA, IL-1 and TNFa and superinduction by CHX are located within the region containing enhancer activity, i.e. between -2350 and -1816. Sequence analysis showed the presence of repetitive sequences of the Alufamily between -2350 and -2140 (18) . Therefore, the region conferring superinducibility on the uPA gene is most likely located in the region between -2140 and -1816. This was confirmed by the following experiments.
Requirement for a NFkB-like binding site for gene induction by PMA and superinduction by CHX Analysis of the DNA sequences within the uPA promoter region showed the presence of several sequences with close similarity to binding sites for known transcription factors. Footprinting analysis demonstrated proteins binding to some of these sequences (19) . The response to PMA in many genes (20) is mediated through the binding of a protein complex of cJun and cFos to DNA elements, termed AP-1 sites. In the region from -1816 to -1480 is one putative binding site each for the AP-1 and AP-2 complexes, at around -1690 and -1580, respectively. However deletion of the region from -1816 to -1480 retained the superinducibility of the gene (Figure 2 ). Other putative protein binding sites are located at -2040 for AP-2 and at -1970 for CREB. Between -1865 and -1835 are two NFkB-like binding sites in a tandem repeat: 5'-CCTGGGAATTTCCTGATAAC-TAACCTGGGAGTTTCGG 3'. The first of the repeats shares 10/10 nucleotides with the consensus sequence 5'-GGGRAyC/T/TYYCC-3'(21), whereas the second repeat shares only 8/10 nucleotides with the consensus sequence. Complementary oligonucleotides, covering either the first (NF3 and NF4) or the second (NF7 and NF8) repeat binding site, were synthesised and cloned into the reporter CAT plasmids pd24CAT and pTKCAT ( Figure 3 ). These plasmids were chosen to test the effects of the NFkB-like sites on the minimal uPA gene promoter and on the minima] thymidine kinase gene promoter, neither of which is regulated by PMA and/or CHX (Table ffl) .
Analysis of the constructs after transfection into HeLa cells showed that one copy of the distal NFkB-like binding site (NF3,4) conferred strong superinducibility on the CAT gene to both promoter constructs (Table HI) . CHX in the absence of PMA had no effect. All constructs, which contained the NF3,4 sequence, could be superinduced by PMA and CHX like the plasmid p2.3CAT. This would indicate that this sequence alone within the uPA gene promoter can confer the superinduction by PMA and CHX. Two pairs of oligonucleotides, containing mutations in the sequence of NF3,4, were synthesised and analysed for their effect on CAT gene activity after cloning into the plasmids pd24 and pTKCAT ( Figure 3 ). These sequences were NF1,2 and NF5,6, respectively (Table I ). The deletion of one basepair of the first NFkB-like repeat (NF1,2), resulting in a change from 10/10 to 9/10 of the consensus sequence, retained the inducibility (Table  HI, Figure 3 , clone pd24NFl,2-7). However, another mutation (NF5,6), which changes the third G-residue in the binding site to a T (Table I) , when placed next to the uPA gene promoter (Figure 3, clone pd24NF5,6-2c) , abolished the inducibility of CAT-activity by PMA and CHX (Table HI) . These results show that the integrity of the NFkB binding site is essential for the transcriptional regulation by PMA and CHX.
The second NFkB-like binding site in the uPA gene promoter cannot confer inducibility by PMA and CHX Synthetic oligonucleotides, containing the second NFkB-like binding site in the uPA gene promoter, located around -1830bp upstream of the transcriptional start site, were cloned into the plasmid pd24. The sequence of this putative binding site (NF7 ,8) is given in Table I and shows two deviations from the consensus sequence for NFkB. Analysis of CAT-activity in HeLa cell extracts showed that the presence of this sequence, in single copy (Figure 3 , clone pd24NF7,8-a) had no effect and in a tandem array of four copies (clone pd24NF7,8-d), had little effect ongene expression levels after treatment of the cells with PMA and CHX (Table HI) . This would indicate that this second repeat of the NFkB-like binding site in the uPA gene promoter is not efficient in conferring regulation by PMA and CHX.
The distal NFkB-like binding site in the uPA promoter confers superinducibility on the gene by EL-1 and TNFa in the presence of CHX The plasmid pTKCATNF3,4e, which contains the distal NFkBlike binding site linked to the minimal promoter of the thymidine kinase gene was transfected into HeLa cells and analysed after incubation of the cells with IL-1 and CHX or TNFa and CHX. The construct was superinduced 100 fold (Table III) . Sequences (NFa,b) in plasmid pd24NFa,b-4, corresponding to the NFkB binding site present in the murine immunoglobulin k-light chain gene (22) , had the same effect (Table HI) . These results show that the presence of binding sites for the transcription factor NFkB allows the transcriptional regulation of a gene by IL-1 and TNFa and superinduction by CHX.
DISCUSSION
Our results suggest that transcription of the human uPA gene is induced by PMA, IL-1 and TNFa by interaction of a transcription factor NFkB-like protein, with its cognate sequence in the promoter region. The transcriptional activation can be superinduced in the presence of CHX, an inhibitor of protein synthesis. A functional NFkB binding site near a minimal promoter is sufficient for the superinduction by PMA, IL-1 or TNFa and CHX. However, a contribution to gene regulation of API and AP2-like binding sites in the promoter region of the human uPA gene cannot be ruled out. The requirement for inhibition of protein synthesis for maximal transcription suggests the presence of a labile transcriptional repressor in HeLa cells which can mediate its effect through a NFkB binding site. Untreated HeLa cells were shown before (23) to be devoid of NFkB. However, PMA, IL-1 and TNFa are known activators of NFkB (22, 24) .
The transcription factor NFkB was first thought to be present only in cells expressing the immunoglobulin genes, i.e. B-cells (25) . Subsequently, its activation by several cytokines and phorbol esters by dissociation from its inhibitor protein, DcB (26) (27) (28) and translocation from the cytoplasm into the nucleus (23, 26, 27) led to speculations about its regulatory involvement in other cell types. Recently, several genes (21), such as those for GM-CSF (29), the IL-2 receptor (30, 31) , TNFa (32), angiotensinogen (33), /3-interferon (34), MHC class I and II (35, 36) and some viral genes (30) , were shown to be regulated through NFkB-like binding sites. Interestingly, most of these genes code for proteins, which are involved in the immune response or inflammatory response.
Analysis of the DNA sequences which bind NFkB revealed that there is a strict requirement for sequences similar to the consensus sequence 5'-GGGRA/C/T/TYYCC (21) . Recently, NFkB, as well as H-2TF1 which binds to similar sequences, were cloned and sequenced and shown to represent the products of different genes (37-39) . The DNA-binding activity of H-2TF1 is not regulated by PMA (35) , and the DNA-binding activity cannot be activated by detergents in cytoplasmic protein extracts. Electrophoretic mobility shift assays (EMSA) performed with cytoplasmic and nuclear protein extracts of untreated and PMA treated HeLa cells showed a pattern of distribution of a protein capable of binding to the synthetic oligonucleotides NF3.4, NF1,2 or NFa.b identical to that expected for NFkB (data not shown). The synthetic oligonucleotides NF5,6 and NF7,8, which failed to enhance transcriptional activity of the reporter CAT-plasmids also failed to bind to cellular proteins.
The only other system, in which the superinduction of transcription by CHX has been investigated in detail, involved the regulation of the fos gene and the actin genes (13, 14) by serum or growth factors. The response to serum is mediated via the serum response element (SRE) (12) , which constitutively binds the serum response factor as shown by in vivo DNA-footprinting (40) . EMSA analysis shows the same DNA/protein complexes for unstimulated and stimulated cells. The superinduction of the fos gene and the actin genes by CHX, like the superinduction of the uPA gene by PMA and CHX, occurred rapidly and reached maximal levels within three to four hours. The induction of the fos gene is limited by the presence of Fos-protein, which is thought to interact with the complexes forming over the serum response element. High levels of Fos-protein in the cells, prior to stimulation with serum, prevents induction of the gene by serum (41) . As the Fos-protein is a short lived protein, it is a possible candidate as a functional repressor in the gene regulation by serum and CHX (33) . However, the regulation of the uPA promoter/CAT gene fusion constructs in HeLa cells by PMA does not appear to be repressible by the Fos-protein, as shown by undiminished induction if the CAT plasmid was co-transfected with the plasmid pBK28 (42) , which directs the expression of high levels of Fos-protein (data not shown). The short lived repressor, which regulates the expression of the uPA gene, is therefore not likely to be the Fos-protein, as has been suggested (43) . We are currently continuing our investigation of the role of the Fos protein in the regulation of the uPA gene.
Given our results implicating the transcription factor NFkB, it is conceivable that the repressor is the NFkB-binding protein, DcB. This cytoplasmic protein is found only as part of the NFkB/IkB complex (26) . Our experiments ( Figure 1C ) indicate that the transcriptional repressor protein is efficiently eliminated after about two hours incubation of the cells with PMA and CHX. Prevention of protein synthesis by treatment of the cells with CHX alone did not lead to the elimination of the repressor. This can be reconciled with the model of a stable complex of NFkB/IkB in the cytoplasm. Phosphorylation of DcB due to protein kinase C (38) leads to the dissociation of the complex and translocation of the NFkB protein into the nucleus. The free IkB might then be rapidly degraded in the cytoplasm. Prevention of new synthesis of IkB might keep NFkB in an active state for a longer period as has been suggested before (25) and allow higher levels of gene transcription to be reached. Incubation of the cells with CHX alone will not disrupt the NFkB/IkB complex and therefore not lead to a rapid activation of NFkB nor to the rapid decay of IkB. Therefore no trancripional activation is observed.
